• Home
  • About
  • UPCOMING WEBINARS & SEMINARS
  • Consultation
  • USP 61/62 FAQ
  • Contact

Barry A. Friedman, PhD LLC

FDA Regulatory Compliance for the Pharmaceutical, Biotechnology and Medical Device Arenas

FIND FDA WARNING LETTERS AND RECALLS THAT DISCUSS THE LATEST REGULATORY THOUGHTS

April 24, 2014 By Barry Friedman 2 Comments

USE “KEY WORDS’ THAT PROVIDE FOCUSED SEARCHES

Barry A Friedman, PhD has been publishing a variety of Regulatory Actions including information regarding Warning Letters, Recalls, and other regulatory activities for over three years.

These 140+ Regulatory Actions often include FDA related activities that are not readily found within the FDA web sites. In addition to these various Regulatory Actions, the Blog includes over 800+ “Key Search” terms where one might focus upon various Regulatory Actions. All of this may be found at: http://barryafriedmanphdllc.wordpress.com/

For those of you that may be interested in Dr. Friedman’s on-going webinars that complement these Regulatory Compliance issues, please visit Pharma Webinars at: http://www.tungstenshield.com/course-list-barry-friedman

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)

Related

Filed Under: 483, Consent Decree, Dietary Supplements, FDA Compliance, Import Alert, Import Ban, Microbiological Issues, New Guidances for Industry, Recall, Regulatory Compliance, Seizure, Warning Letters, Webinar Tagged With: Barry A Friedman PhD, Barry A Friedman PhD LLC, FDA activities, key search terms, pharmaceutical webinars, regulatory actions

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Comments

  1. dcaves59 says

    October 7, 2014 at 9:41 am

    Hello

    Wanted to know FDA Consultant and FDA Warning Letters
    for a long time, finally I found this site and got all the required info, so happy with the service.

    Thanks
    David

    Reply
    • Barry A. Friedman, PhD LLC says

      February 17, 2015 at 10:40 pm

      Thanks so much for your kind words.

      Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

New Reader? Learn More

Connect With Me:

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Webinar Registration & Information

FREQUENTLY ASKED QUESTIONS:

FDA Form 483 Frequently Asked Questions

USP General Chapter

USP General Chapter 62, Part II

TOP OBSERVATIONS:

FDA’s CDER LISTING OF TOP NINETEEN OBSERVATIONS FOR 2014

FDA CDER Most Frequent Form FDA 483 Observations Fiscal Year 2012

CDER MOST FREQUENTLY CITED DRUG OBSERVATIONS – FISCAL YEAR 2010

Top Posts:

Top Posts for 2012

Top Posts for 2013

Top Posts Year To Date

Recent Posts

  • Upcoming Microbiological Webinars
  • Microbiological Webinars
  • Microbiological Webinars 2020 (Upcoming)
  • General Chapter (USP<60>) on B. cepacia Complex to Issue December 1, 2019
  • Les Produits Chimiques B.G.R., Inc. Receives FDA Warning Letter (07/24/2018) for Failure to Perform Laboratory Testing

Categories

follow us in feedly
  • Home
  • About
  • UPCOMING WEBINARS & SEMINARS
  • Consultation
  • USP 61/62 FAQ
  • Contact
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Thank You For Visiting Barry A. Friedman, PhD LLC - 2015

Welcome To My Blog!
Please enter your name and email below to receive my newsletter.
Your information will *never* be shared or sold to a 3rd party.